# International Infusion

International Infusion is an Asset Manager based in Research Triangle, United States.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Research Triangle, United States
- **Region:** North America
- **Address:** Chicago, IL, United States
- **Founded:** 2009
- **Assets under management:** Undisclosed
- **Website:** infusion51a.com
- **LinkedIn:** linkedin.com/company/international-infusion

## Regulatory record

- **Reports private funds:** No

## About

Infusion 51a is an impact-focused investment fund on a mission to invest in, develop, and advance world-changing innovation. Initially, it seeks disruptive precision-based opportunities within the life sciences. Nestled in the heart of the US research triangle in North Carolina, it is dedicated to fostering the advancement of groundbreaking health solutions worldwide. Since 2015, the fund has been allocating both financial and human capital into vetted opportunities with the potential to disrupt the life-science ecosystem.

## Sectors

- Life Sciences
- Healthcare

## People

- Jeff Stephens — General Partner
- Scott VanderMeer — MBA, General Partner
- Chirag Patel — Director of Technology
- Brett Logan — JD, Securities Counsel
- Krishn Patel — Director of Data Collection
- Todd Smith — MBA, Chief Commercial Officer
- Monica Coleman — CPA, Finance Consultant
- Mehrab Ajalli — Director of Strategic Growth in the MENA Region

## Questions

### What investment stages does International Infusion target?

The firm's strategy covers seed and early-stage venture, expansion and late-stage growth, management buyouts, PIPEs, recapitalizations, reorganizations, and turnarounds. It also pursues pre-IPO and private-to-public hybrid transactions. This lifecycle-agnostic approach is unusual — most managers specialize in either venture or distressed, but International Infusion operates across both extremes.

### Is International Infusion a venture capital firm or a private equity firm?

It is neither exclusively. The firm's mandate includes venture, growth, buyouts, and distressed situations, making it closer to a hybrid or merchant-banking model. Its inclusion of PIPEs, restructurings, and pre-IPO hybrids places it outside conventional fund categories.

### Who runs investment decisions at International Infusion?

No named principals are currently in the public record. The firm maintains a deliberately low profile, and no individuals have been identified through official filings, press coverage, or the firm's limited web presence.

## Related profiles

- [Intermedia Iniziative](https://altss.com/profile/intermedia-iniziative)
- [International Investment & Underwriting](https://altss.com/profile/international-investment-underwriting)

---

Last updated: 2026-08-11T15:07:05.535Z

Canonical page: https://altss.com/profile/international-infusion

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology